Assessment of Sensory Block Distribution and Postoperative Analgesia Following Ultrasound-Guided Interfascial Plane Blocks in Living Liver Donors: A Prospective Observational Study

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Living liver donor hepatectomy at our institution routinely includes ultrasound-guided interfascial plane blocks as part of postoperative analgesia. Although these blocks have become increasingly used in donor hepatectomy, their cutaneous sensory distributions and block-related dermatomal coverage have not been systematically evaluated, with only anecdotal reports available in the literature. This prospective observational study aims to assess both the sensory blockade patterns and the early postoperative analgesic performance of interfascial plane blocks administered to living liver donors. Following surgery, all consenting donors receive the institution's standard block protocol. Cutaneous sensory mapping is performed in the post-anesthesia care unit (PACU) at the second postoperative hour. Pain intensity and analgesic requirements within the first 24 hours are also recorded. The study is designed to provide objective data on the dermatomal coverage and postoperative analgesic effects of contemporary ultrasound-guided interfascial plane blocks used in living liver donor surgery.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
View:

• Adult living liver donors undergoing elective donor hepatectomy

• Age 18 to 65 years

• ASA physical status I-II

• Patients who have received ultrasound-guided interfascial plane blocks as part of their postoperative analgesia

• Ability to cooperate with postoperative sensory mapping procedures

• Patients who agree to participate and provide written informed consent

Locations
Other Locations
Turkey
Bahcesehir Unişversity Medicalpark Goztepe hospital
RECRUITING
Istanbul
Contact Information
Primary
Selma Kahyaoglu
selmabsygt@hotmail.com
+905053705332
Backup
Serkan Tulgar
serkantulgar.md@gmail.com
+905055423985
Time Frame
Start Date: 2025-11-01
Estimated Completion Date: 2026-01
Participants
Target number of participants: 20
Related Therapeutic Areas
Sponsors
Leads: Bahçeşehir University

This content was sourced from clinicaltrials.gov